Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India, says GlobalData
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The new facility will be able to handle four times as many patients as the previous facility.
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
Subscribe To Our Newsletter & Stay Updated